98247548 - CRISPR-X

Information

• Trademark
• 98247548

• Source

• Serial Number

  98247548

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 31, 2023
  a year ago

• Transaction Date

  January 01, 2025
  3 days ago

• Status Date

  December 16, 2024
  19 days ago

• Published for Opposition Date

  January 07, 2025
  2 days from now

• Location Date

  December 16, 2024
  19 days ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MCCRARY, LISA

• Attorney Docket Number

  33324/60084

  Attorney Name

  Tiffany D. Gehrke

  Law Office Assigned Location Code

  M50

• Owners

  • Crispr Therapeutics AG

Case File Statements

• DM0000: The mark consists of the stylized wording "CRISPR-X", with the "X" being formed with curved edges ending in a point with three horizontal lines between the top two arms of the "X" and three horizontal lines between the bottom two arms of the "X".
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Case File Event Statements

• 11/3/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/8/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/9/2023 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/1/2024 - 8 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/9/2024 - 8 months ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/9/2024 - 8 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/9/2024 - 8 months ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/8/2024 - 4 months ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/8/2024 - 4 months ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/8/2024 - 4 months ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/10/2024 - 25 days ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/1/2025 - 3 days ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP